Retraction
Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
Paper Information
Record ID:
61888
Journal:
Publication Date:
October 20, 2021
Retraction Date:
October 11, 2023
(2.1 years years ago)
Subjects:
Institutions:
Article Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9796148Citations (17)
17
Total Citations6
Post-Retraction(35.3%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
0
After 2+ years
453
Days since retraction (latest)
FAM83A-AS1 predicts severe development of non-small cell lung cancer and adverse postoperative prognosis of thoracotomy
Feng Tang, Yuemian Liang, Licai Zhang et al. (5 authors)
Journal of Cardiothoracic Surgery
Open Access
Published: Jan 2025
453 days after retraction
Diagnostic value of joint detection of serum tumor markers in different pathological types of lung cancer
Wei Liu, D.Y. Zang
International Journal of Radiation Research
Published: Apr 2024
173 days after retraction
HSP90: A promising target for NSCLC treatments
Yue Zhu, Zhaoxia Dai
European Journal of Pharmacology
Published: Feb 2024
3 citations
3 citations
114 days after retraction
Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases
Jinxian He, Gaofeng Liang, Hongyan Yu et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Jan 2024
5 citations
5 citations
90 days after retraction
Enhancing safety and therapeutic efficacy: PD-1 inhibitor and recombinant human endostatin combination in advanced non-small cell lung cancer patients
Shuhong Wang, Min Yang, Dan Chen et al. (4 authors)
American Journal of Translational Research
Open Access
Published: Jan 2024
1 citation
1 citation
82 days after retraction
Meta-Analysis of Diagnostic Value of Heat Shock Protein 90α in Lung Cancer Patients
晨 陈
Advances in Clinical Medicine
Published: Jan 2024
1 citation
1 citation
82 days after retraction
Synthesis and Validation of the First Cell-Impermeable Hsp90α-Selective Inhibitors
Tyelor S. Reynolds, Brian S. J. Blagg
ACS Medicinal Chemistry Letters
Published: Aug 2023
7 citations
7 citations
64 days before retraction
Evaluation of the monocyte-to-lymphocyte ratio (MLR) and C-reactive protein (CRP) as diagnostic biomarkers in different lung diseases, especially for SCLC
Yue Zhang, Zhigang Xin, Qun Zhang et al. (5 authors)
Turkish Journal of Biochemistry
Open Access
Published: Jul 2023
77 days before retraction
Ultrasensitive Sandwich-Type Electrochemical Aptasensor for Dual Detection of Lung Cancer Biomarkers
Hai Jiang, Hang Zhang, Mei Qin et al. (5 authors)
IEEE Sensors Journal
Published: Jul 2023
6 citations
6 citations
85 days before retraction
A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter
Jianhao Qiu, Rongyang Li, Yukai Wang et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Jun 2023
1 citation
1 citation
125 days before retraction
Predictive Value of Serum Heat Shock Protein 90α on the Prognosis of Patients with Lung Adenocarcinoma
Yue Fang, Zhichao Yuan, Hao Zhang et al. (5 authors)
Journal of Inflammation Research
Open Access
Published: Mar 2023
4 citations
4 citations
224 days before retraction
The critical role of serum thymidine kinase 1(STK1) in predicting prognosis for immunotherapy in T4 stage lung squamous cell carcinoma
Jinmiao Pan, Haizhou Liu, Shirong Li et al. (9 authors)
Heliyon
Open Access
Published: Feb 2023
1 citation
1 citation
226 days before retraction
Retracted: Impact of HSP90<i>α</i>, CEA, NSE, SCC, and CYFRA21‐1 on Lung Cancer Patients
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
1 citation
1 citation
283 days before retraction
A microfluidic immunosensor for automatic detection of carcinoembryonic antigen based on immunomagnetic separation and droplet arrays
Haoran Hu, Gaozhe Cai, Zehang Gao et al. (10 authors)
The Analyst
Published: Jan 2023
12 citations
12 citations
283 days before retraction
Structure–Activity Relationship Study of Tertiary Alcohol Hsp90α-Selective Inhibitors with Novel Binding Mode
Sanket Mishra, Tyelor S. Reynolds, Taylor Merfeld et al. (8 authors)
ACS Medicinal Chemistry Letters
Open Access
Published: Nov 2022
12 citations
12 citations
341 days before retraction
Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer
Huijuan Bi, Lina Yin, Wenhao Fang et al. (6 authors)
Laboratory Medicine
Published: Oct 2022
28 citations
28 citations
351 days before retraction
High Expression of Plasma Extracellular HSP90α is Associated With the Poor Efficacy of Chemotherapy and Prognosis in Small Cell Lung Cancer
Baoyue Huang, Jinmiao Pan, Haizhou Liu et al. (9 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Jul 2022
6 citations
6 citations
457 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025